ORGO logo

Organogenesis Holdings Inc. Class A Common Stock


ORGO: Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.


Show ORGO Financials

Consumer Interest
SEC Filings

Recent trades of ORGO by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by ORGO's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Oral tissue regeneration and repair Oct. 10, 2017
  • Patent Title: Tissue repair fabric Mar. 22, 2011
  • Patent Title: Method and apparatus for inducing controlled mechanical constraints in a tissue construct Mar. 15, 2011
  • Patent Title: Bioengineered tissue constructs and methods for producing and using thereof Nov. 02, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ORGO in WallStreetBets Daily Discussion


Recent insights relating to ORGO

CNBC Recommendations

Recent picks made for ORGO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ORGO

Corporate Flights

Flights by private jets registered to ORGO